First Horizon Advisors’s Usana Health Sciences USNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-8
Closed -$468 2458
2023
Q3
$468 Sell
8
-23
-74% -$1.44K ﹤0.01% 2319
2023
Q2
$1.95K Sell
31
-15
-33% -$955 ﹤0.01% 2082
2023
Q1
$2.89K Hold
46
﹤0.01% 1988
2022
Q4
$2.45K Hold
46
﹤0.01% 2010
2022
Q3
$2K Buy
46
+10
+28% +$661 ﹤0.01% 2040
2022
Q2
$2K Buy
+36
New +$2.68K ﹤0.01% 2128
2022
Q1
Sell
-19
Closed -$1K 2283
2021
Q4
$1K Sell
19
-10
-34% -$998 ﹤0.01% 2174
2021
Q3
$2K Hold
29
﹤0.01% 2028
2021
Q2
$2K Hold
29
﹤0.01% 1802
2021
Q1
$2K Hold
29
﹤0.01% 1705
2020
Q4
$2K Buy
29
+11
+61% +$851 ﹤0.01% 1335
2020
Q3
$1K Buy
+18
New +$1.44K ﹤0.01% 1387
2015
Q2
Sell
-44
Closed -$2K 1507
2015
Q1
$2K Buy
+44
New +$2.25K ﹤0.01% 1375

Other funds holding USNA

First Horizon Advisors's USNA Position: Q4 2023 in Review

First Horizon Advisors sold out of Usana Health Sciences (USNA) in Q4 2023, closing a stake of 8 shares — an estimated $468 sold.

First Horizon Advisors first reported a position in USNA in Q1 2015 and held it in 13 quarters. The position peaked at $2.89K in Q1 2023. 167 funds tracked by Wall St. Rank hold USNA as of Q4 2023.

  • First Horizon Advisors reported no remaining Usana Health Sciences position as of Q4 2023 after selling out during the quarter.
  • First Horizon Advisors sold 8 Usana Health Sciences shares in Q4 2023, an estimated $468.
  • First Horizon Advisors first reported a position in Usana Health Sciences in Q1 2015 and held it in 13 quarters.
  • First Horizon Advisors's Usana Health Sciences position peaked at $2.89K in Q1 2023.
  • 167 funds tracked by Wall St. Rank held Usana Health Sciences as of Q4 2023.

Based on First Horizon Advisors's 13F filing for Q4 2023, filed 6 Feb 2024.